Copenhagen Master Observational Trial
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRigshospitalet, Denmark
About this trial
The primary objectives of this prospective non-interventional study (NIS) are to assess and describe outcomes in relation to biomarkers, including whole-genome sequencing (WGS) in patients with non- small cell lung cancer (NSCLC) or breast cancer receiving treatment offered in the clinic (standard of care or included in clinical trials).
Eligibility criteria
Qualifiers
Patients (≥ 18 years of age) with diagnosis of NSCLC or breast cancer amenable to medical or radiation therapy with curative or palliative intent
Evidence of a personally signed and dated informed consent form document indicating that the patient has been informed of all pertinent aspects of the study
Able to read and understand Danish
Willing and able to complete collection of data including WGS
Disqualifiers
Patient with breast cancer initiating adjuvant systemic therapy
In the judgment of the investigator, the patient's life expectancy is fewer than 3 months at the time of diagnosis of NSCLC or breast cancer
Trial design
Treatments tested in this trial
- No Intervention: Observational Cohort
Treatment groups
2,400 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov